Evidence map›Paper›PMID 31950326›Full record

ArticleMolecular biology reports2020

Low-oxygen and knock-out serum maintain stemness in human retinal progenitor cells.

Deepti Singh, Pierre C Dromel, Michael Young

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Deepti Singh *Schepens Eye Research Institute of Massachusetts Ear and Eye, Harvard Medical School, 20 Staniford Street, Boston, MA, 02114, USA.
Pierre C Dromel *Schepens Eye Research Institute of Massachusetts Ear and Eye, Harvard Medical School, 20 Staniford Street, Boston, MA, 02114, USA.
Michael YoungSchepens Eye Research Institute of Massachusetts Ear and Eye, Harvard Medical School, 20 Staniford Street, Boston, MA, 02114, USA. michael_young@meei.harvard.edu.ORCID http://orcid.org/0000-0002-6932-5159
Massachusetts Eye and Ear Infirmary · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using stem and progenitor cells to treat retinal disorders holds great promise. Using defined culture conditions to maintain the desires phenotype is of utmost clinical importance. We cultured human retinal progenitor cells (hRPCs) in different conditions: such as normoxia (20% oxygen), and hypoxia (5% oxygen) with and without knock-out serum replacement (KOSR) to evaluate its effect on these cells. KOSR is known nutrient supplement often used to replace bovine serum for culturing embryonic or pluripotent stem cells, especially those destined for clinical applications. The purpose of this study was to identify the impact of different environmental and chemical cues to determine if this alters the fate of these cells. Our results indicate that cells cultured with or without KOSR do not show significant differences in viability, but that the oxygen tension can significantly change their viability (higher in hypoxia than normoxia). However, cells with KOSR in hypoxia condition expressed significantly higher stemness markers such as C-myc and Oct4 (31.20% and 13.44% respectively) in comparison to hRPCs cultured in KOSR at normoxia (12.07% and 4.05%). Furthermore, levels of markers for retinal commitment such as rhodopsin were significantly lower in the KOSR supplemented cells in hypoxia culture compared to normoxia. KOSR is known to improve proliferation and maintain stemness of embryonic cells and our experiments suggest that hRPCs maintain their proliferation and stemness characteristics in hypoxia with KOSR supplement. Normoxia, however, results in mature cell marker expression, suggesting a profound effect of oxygen tension on these cells.

Indexed as

AnimalsCattleCell Culture TechniquesCell HypoxiaCell ProliferationCells, CulturedCell SurvivalCulture Media, Serum-FreeHumansOctamer Transcription Factor-3OxygenProto-Oncogene Proteins c-mycRetinaRhodopsinSerum Albumin, BovineStem CellsCulture Media, Serum-FreeMYC protein, humanOctamer Transcription Factor-3OxygenPOU5F1 protein, humanProto-Oncogene Proteins c-mycRhodopsinSerum Albumin, BovineFlow cytometerHuman retinal progenitor cellsHypoxiaStemness

Identifiers

PMID31950326
OpenAlexW3000179072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.